[
  {
    "ts": null,
    "headline": "Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025",
    "summary": "The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.",
    "url": "https://finnhub.io/api/news?id=5893587e5fa3e91a37b6975c5ceac34f7fc311555b4dc90278e6109cce22d835",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736791802,
      "headline": "Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025",
      "id": 132390023,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1886168184/image_1886168184.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.",
      "url": "https://finnhub.io/api/news?id=5893587e5fa3e91a37b6975c5ceac34f7fc311555b4dc90278e6109cce22d835"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More",
    "summary": "These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More",
    "url": "https://finnhub.io/api/news?id=117796fc151b752380b019d1fb8e1bfeebbaf28f221e1faf3fa78320e2936a92",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736785440,
      "headline": "These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More",
      "id": 132537815,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More",
      "url": "https://finnhub.io/api/news?id=117796fc151b752380b019d1fb8e1bfeebbaf28f221e1faf3fa78320e2936a92"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.",
    "summary": "Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.",
    "url": "https://finnhub.io/api/news?id=9666d42af5f92b332f641a9546c554b4fcef3519c28d1a114dcde611bf9951f7",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736785123,
      "headline": "Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.",
      "id": 132537794,
      "image": "",
      "related": "MRNA",
      "source": "DowJones",
      "summary": "Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.",
      "url": "https://finnhub.io/api/news?id=9666d42af5f92b332f641a9546c554b4fcef3519c28d1a114dcde611bf9951f7"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Jones Up, Donald Trump Stock Rockets; Mark Zuckerberg Says This, Rocks Quantum Stocks (Live Coverage)",
    "summary": "Stock Market Today: Dow Jones Up, Donald Trump Stock Rockets; Mark Zuckerberg Says This, Rocks Quantum Stocks (Live Coverage)",
    "url": "https://finnhub.io/api/news?id=75cd57591e6885fec1cc5aedd39464bf3d210894c241eba976faf88f73adf95c",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736784703,
      "headline": "Stock Market Today: Dow Jones Up, Donald Trump Stock Rockets; Mark Zuckerberg Says This, Rocks Quantum Stocks (Live Coverage)",
      "id": 132407419,
      "image": "",
      "related": "MRNA",
      "source": "DowJones",
      "summary": "Stock Market Today: Dow Jones Up, Donald Trump Stock Rockets; Mark Zuckerberg Says This, Rocks Quantum Stocks (Live Coverage)",
      "url": "https://finnhub.io/api/news?id=75cd57591e6885fec1cc5aedd39464bf3d210894c241eba976faf88f73adf95c"
    }
  },
  {
    "ts": null,
    "headline": "Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints",
    "summary": "Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints",
    "url": "https://finnhub.io/api/news?id=8d2a41fd5b57c2a72a00615bfd028e67e0f407194c6320aa3af1ed94dbf71b94",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736779920,
      "headline": "Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints",
      "id": 132537816,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints",
      "url": "https://finnhub.io/api/news?id=8d2a41fd5b57c2a72a00615bfd028e67e0f407194c6320aa3af1ed94dbf71b94"
    }
  },
  {
    "ts": null,
    "headline": "Moderna’s Struggles Could Complicate Bird Flu Fight. What It Means for a Potential Vaccine.",
    "summary": "Moderna’s Struggles Could Complicate Bird Flu Fight. What It Means for a Potential Vaccine.",
    "url": "https://finnhub.io/api/news?id=b49b791a85624d70329089751f45173367b863da16acc80bd55474651e493fb4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736776740,
      "headline": "Moderna’s Struggles Could Complicate Bird Flu Fight. What It Means for a Potential Vaccine.",
      "id": 132537817,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Moderna’s Struggles Could Complicate Bird Flu Fight. What It Means for a Potential Vaccine.",
      "url": "https://finnhub.io/api/news?id=b49b791a85624d70329089751f45173367b863da16acc80bd55474651e493fb4"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Shares Drop to Five-Year Low After Slashing Revenue, Sales Forecasts",
    "summary": "Moderna Shares Drop to Five-Year Low After Slashing Revenue, Sales Forecasts",
    "url": "https://finnhub.io/api/news?id=8aec61ec1322877afe0f316edee03a4e1f7614c857844aeb5dd7c24f29637400",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736769780,
      "headline": "Moderna Shares Drop to Five-Year Low After Slashing Revenue, Sales Forecasts",
      "id": 132537818,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Moderna Shares Drop to Five-Year Low After Slashing Revenue, Sales Forecasts",
      "url": "https://finnhub.io/api/news?id=8aec61ec1322877afe0f316edee03a4e1f7614c857844aeb5dd7c24f29637400"
    }
  },
  {
    "ts": null,
    "headline": "Moderna surprises the Street by predicting a bigger-than-expected sales drop",
    "summary": "Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5...",
    "url": "https://finnhub.io/api/news?id=b84d404a129a8d6b6c5768f4677753a3ecaf286d66a88eff10059625c936a501",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736760005,
      "headline": "Moderna surprises the Street by predicting a bigger-than-expected sales drop",
      "id": 132387620,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5...",
      "url": "https://finnhub.io/api/news?id=b84d404a129a8d6b6c5768f4677753a3ecaf286d66a88eff10059625c936a501"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast.",
    "summary": "Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast.",
    "url": "https://finnhub.io/api/news?id=44c01c4ecf944e20c0b970968332a9a6e5fb8c34c36254940acf3e25c43aa936",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736758260,
      "headline": "Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast.",
      "id": 132408339,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast.",
      "url": "https://finnhub.io/api/news?id=44c01c4ecf944e20c0b970968332a9a6e5fb8c34c36254940acf3e25c43aa936"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: plans to cut costs by E1bn by 2025",
    "summary": "Moderna announces commercial updates and progress in its pipeline of mRNA-based drugs. For example, the laboratory has shared positive immunogenicity data for its combination influenza vaccine and...",
    "url": "https://finnhub.io/api/news?id=013707380f1a03bd376d26d38842a29e2d0bdfe9a5144597a33d2302a1684186",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736757375,
      "headline": "Moderna: plans to cut costs by E1bn by 2025",
      "id": 132387368,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna announces commercial updates and progress in its pipeline of mRNA-based drugs. For example, the laboratory has shared positive immunogenicity data for its combination influenza vaccine and...",
      "url": "https://finnhub.io/api/news?id=013707380f1a03bd376d26d38842a29e2d0bdfe9a5144597a33d2302a1684186"
    }
  },
  {
    "ts": null,
    "headline": "Moderna 2025 Revenue Guidance Below Wall Street’s Estimates",
    "summary": "Moderna 2025 Revenue Guidance Below Wall Street’s Estimates",
    "url": "https://finnhub.io/api/news?id=d8330c7649bc36ce50f136cea6a4caf87994a440cd51bb29f3758a411eaabf9c",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736755560,
      "headline": "Moderna 2025 Revenue Guidance Below Wall Street’s Estimates",
      "id": 132537796,
      "image": "",
      "related": "MRNA",
      "source": "DowJones",
      "summary": "Moderna 2025 Revenue Guidance Below Wall Street’s Estimates",
      "url": "https://finnhub.io/api/news?id=d8330c7649bc36ce50f136cea6a4caf87994a440cd51bb29f3758a411eaabf9c"
    }
  },
  {
    "ts": null,
    "headline": "Biotechs active in premarket trade",
    "summary": "Biotechs active in premarket trade",
    "url": "https://finnhub.io/api/news?id=138c0c6ca3623c10b47f0eea895be87785e33865832551a5613921d36f7307f9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736753936,
      "headline": "Biotechs active in premarket trade",
      "id": 132537820,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Biotechs active in premarket trade",
      "url": "https://finnhub.io/api/news?id=138c0c6ca3623c10b47f0eea895be87785e33865832551a5613921d36f7307f9"
    }
  },
  {
    "ts": null,
    "headline": "Moderna cuts 2025 sales forecast by $1 billion on weak vaccine demand, shares fall",
    "summary": "-Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus shot and weak demand for COVID-19 vaccines, sending its shares down more than...",
    "url": "https://finnhub.io/api/news?id=cbca8fe0cb8b2ea98ba1128b164bc3bbac576f7e4a4864eb687212167104e1b2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736753767,
      "headline": "Moderna cuts 2025 sales forecast by $1 billion on weak vaccine demand, shares fall",
      "id": 132386936,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "-Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus shot and weak demand for COVID-19 vaccines, sending its shares down more than...",
      "url": "https://finnhub.io/api/news?id=cbca8fe0cb8b2ea98ba1128b164bc3bbac576f7e4a4864eb687212167104e1b2"
    }
  },
  {
    "ts": null,
    "headline": "Moderna cuts 2025 sales view on slow start to RSV shot, weak COVID vaccine demand",
    "summary": "Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of its respiratory syncytial virus shot and weak demand for COVID-19 vaccines. It expects $1.5 billion...",
    "url": "https://finnhub.io/api/news?id=417fb6a5744489c2379eed872ade3a4e6adff25f4a2b697106fb851e8acac82a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736751876,
      "headline": "Moderna cuts 2025 sales view on slow start to RSV shot, weak COVID vaccine demand",
      "id": 132386764,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of its respiratory syncytial virus shot and weak demand for COVID-19 vaccines. It expects $1.5 billion...",
      "url": "https://finnhub.io/api/news?id=417fb6a5744489c2379eed872ade3a4e6adff25f4a2b697106fb851e8acac82a"
    }
  }
]